BackInnoviva Overview
Innoviva Inc

Innoviva Target Price

Where could INVA trade next? Consensus target price: $38.

Get informed when a big investor buys or sells

+ Follow

Share Price

$21.25

Average Target Price

$38.0078.8% upside

2 analysts in the last 4 months

High: $42 | Low: $34

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-07Cantor Fitzgerald$3460% upsideOpen
2026-05-07BTIG$4297.6% upsideOpen
2026-02-26Cantor FitzgeraldSteve Seedhouse$3250.6% upsideOpen
2026-02-17BTIG$3564.7% upsideOpen
2025-12-16H.C. Wainwright$46116.5% upsideOpen
2025-09-30Goldman Sachs$1720% downsideOpen
2025-08-11OppenheimerTrevor Allred$3564.7% upsideOpen
2025-03-07Scotiabank$55158.8% upsideOpen
2022-08-08Morgan Stanley$1338.8% downsideOpen
2022-07-15Morgan Stanley$1243.5% downsideOpen

Innoviva (INVA) FAQ

Innoviva (INVA) currently reports a target price of $38. Use the charts on this page to explore Innoviva's target price history and peer comparisons.

Analysts' average 12-month price target for Innoviva is $38, about 78.8% upside from the current share price of $21.25. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $38, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Innoviva, and consider following INVA for alerts when major investors trade the stock.

Innoviva is classified in the Healthcare sector. On target price, it currently shows $38. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing INVA with unrelated industries.